EOM Pharmaceuticals Holdings, Inc. is a clinical-stage pharmaceutical company focused on the development of novel therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its development pipeline consists of multiple programs and clinical indications at various stages of development. The company was founded by Eli Goldberger and is headquartered in Montvale, NJ.